Macrophages play central roles in immunity and homeostasis, and contribute to the pathogenesis of atherosclerosis through their accumulation of cholesterol and the production of inflammatory mediators and cytokines. Recent studies indicate that oxysterols influence diverse aspects of macrophage biology. Rather than simply being intermediates of cholesterol catabolism, oxysterols are also potent bioactive lipids that regulate lipid metabolism, immune function, and cytotoxicity. These functions are mediated by specific oxysterol sensors, including liver X receptors (LXR), Insigs, and members of the oxysterol binding protein (OSBP) and OSBP-related protein family. The mechanisms of oxysterol-induced functions and their physiological roles in macrophages are reviewed. (Circ J 2010; 74: 2045 - 2051 
ardiovascular disease, including atherosclerosis, is the leading cause of morbidity and mortality in Western countries. Atherosclerosis is a chronic inflammatory disease, as well as a disorder of lipid metabolism. Although many epidemiological studies have shown that high concentrations of low-density lipoprotein (LDL) cholesterol are a major risk factor for atherosclerosis, innate immunity pathways have long been suspected to contribute to the initiation and progression of atherosclerosis. In fact, a systemic inflammatory reaction is combined with an accumulation of immune cells, such as monocytes/macrophages, dendritic cells, and numerous lymphocytes, in atherosclerotic plaques, and recent studies have also demonstrated that the heterogeneity of the leukocyte subsets participates in the pathogenesis of atherosclerosis. 1-4 Atherosclerotic lesion progression has been shown to depend on persistent, chronic inflammation in the artery wall. 5 After induction of hyperlipidemia, a rapid influx of monocytes into the arterial intima occurs; if persistent, this influx generates the chronic inflammation characteristic of the atherosclerotic plaque. 6 Many proinflammatory genes activated by pathogen engagement of innate immunity signaling pathways are also induced in macrophages present in atherosclerotic lesions.
The accumulation of cholesterol-loaded macrophages "foam cells" in the arterial wall is the hallmark of the early atherosclerotic lesion. 7, 8 In response to lipid loading, macrophages activate a compensatory pathway for cholesterol efflux mediated by the ATP-binding cassette transporters ABCA1 and ABCG1. 9, 10 In the face of systemic hypercholesterolemia, however, this homeostatic mechanism is overwhelmed, leading to the development of foam cells and the fatty streak lesion. In fact, a combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. 11 Cholesterol loading of macrophages stimulates the production of inflammatory mediators, such as cytokines and reactive oxygen species, which recruit other cell types and contribute to the development of a complex lesion. 12 Thus, processes that interfere with the intracellular cholesterol balance would be expected to exacerbate lesion formation. Taken together, alterations in both lipid metabolism and the immune responses in macrophages play a significant role in promoting the development of atherosclerotic lesions. 5, 13 Knowledge of the mechanisms that regulate these responses could therefore be of considerable value with respect to the development of new approaches to prevention and treatment.
Oxysterols are derivatives of enzymatic or nonenzymatic cholesterol oxidation. The cellular content of oxysterols is dependent on intracellular cholesterol biosynthesis, biosynthesis of bile acids and steroid hormones, and uptake from exogenous sources, such as oxidized lipoproteins. Although oxysterols have sometimes been thought to simply be intermediates in cholesterol catabolism, studies over the past 2 decades suggest that oxysterols are bioactive lipids that act as regulators of lipid metabolism, inflammation, and as toxic factors that contribute to clinical complications of atherosclerosis. Oxysterols may therefore be involved in the initiation and progression of chronic disease. In fact, many clinical studies have reported that oxysterols are elevated in patients with obesity, diabetes, hypercholesterolemia, and atherosclerosis. 14-18 These findings suggest that oxysterol levels in macrophages may play an important role in the cross-talk between lipid metabolism and immune regulation in chronic diseases. Oxysterols levels in cultured macrophages are very low under normal conditions, but can change dramatically in response to various perturbations. Recently, using mass spectrometry technology, the LIPID MAPS Consortium (http: //www.lipidmaps.org/) documented the presence of detectable
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levels of several oxysterols, including 7α-hydroxycholesterol, 7-ketocholesterol, 4β-hydroxycholesterol, 22(R)-hydroxycholesterol, 24(S), 25-epoxycholesterol, 25-hydroxycholesterol, and 27-hydroxycholesterol in mouse-elicited peritoneal macrophages and bone-marrow-derived macrophages. These oxysterols can be generated by nonenzymatic production, enzymatic production, or both. Cholesterol oxidation by free radicals lead to the production of 7α-hydroxycholesterol and 7-ketocholesterol. 19 Some cytochrome P450 enzymes convert cholesterol to particular oxysterols; CYP3A4 produces 4β-hydroxycholesterol; 20 CYP7A1 produces 7α-hydroxycholesterol, which is the first rate-limiting step in the classical bile acid pathway; and the mitochondrial enzyme CYP27A1 produces 27-hydroxycholesterol, which is the initial step in the oxidation of the side chain of sterol intermediates in the classical and alternative bile acid pathway. 21 On the other hand, some oxysterols are produced by non-cytochrome P450 enzymes; for example, 25-hydroxycholesterol is produced by cholesterol 25 hydroxylase that is a member of a small family of enzymes that utilize di-iron cofactors to catalyze the hydroxylation of hydrophobic substrates. 22 24(S), 25-epoxycholesterol is produced in a shunt of the same mevalonate pathway for cholesterol, begining with squalene epoxidase. 23 In this review, we discuss the functions of some of these oxysterols in macrophages. These actions of LXRs function in a complimentary manner with the SREBP pathway, described in further detail later, to regulate coordinated cellular cholesterol and fatty acid homeostasis.
To positively regulate gene expression, LXRs form obligate heterodimers with RXRs, which are related members of the nuclear receptor superfamily that can be regulated by 9-cis-retinoic acid and long-chain polyunsaturated fatty acids. 30-32 LXR/RXR heterodimers regulate their target genes by recognizing specific LXR-response elements (LXRE) consisting of 2 direct hexanucleotide repeats separated by 4 nucleotides. 33 However, the expression patterns of LXR target genes are cell-type specific. To gain insights into how these specific patterns are established, we recently performed chromatin immunoprecipitation coupled to deep sequencing (ChIP-Seq) to define the LXRβ cistrome in macrophages. 34 The studies were performed in parallel with genome-wide location analysis of histone modifications that are associated with promoters and/or enhancers, as well as the transcription factors that are required for macrophage differentiation. ChIP-Seq analysis of LXRβ defined hundreds of high-confidence binding sites in macrophages. Although some binding sites were in close proximity to promoters of LXR target genes, the vast majority were associated with enhancer-like elements (characterized by the presence of histone H3 monomethylated at lysine 4) located in intergenic regions or within introns. Our recent studies indicate that these enhancer-like elements are established by collaborative interactions between small sets of lineage-determining transcription factors that include the macrophage and B-cell-specific factor, PU.1 and C/EBP transcription factors. 34 Consistent with this, de novo motif analysis of genomic LXR binding sites not only identified the consensus LXRE as the most highly enriched sequence motif, but also recovered the PU.1 recognition motif as a highly co-enriched sequence. In line with motif enrichment, 34% of LXRβ peaks were within 100 bp of a PU.1-bound site in macrophages. LXRβ recruitment to sites with vicinal PU.1 binding (within 100 bp) was PU.1-dependent. This was not the case for LXRβ-binding sites that were not in close proximity to PU.1, indicating that PU.1 determines LXR binding in a spatially restricted manner and is required for a significant component of LXR-dependent gene expression in macrophages. 34 Collectively, these findings suggest that small sets of lineage-determining factors establish cell-specific enhancer elements that enable LXRs to execute their cell-specific functions.
Oxysterol-Regulated LXR Transrepression Pathways
Recent studies have also revealed that the activation of LXRs by oxysterols or synthetic agonists in macrophages inhibits Toll like receptor (TLR)-inducible inflammatory genes, such as inducible nitric oxide synthase (iNOS), interleukin-1β, and monocyte chemoattractant protein-1, by interfering with nuclear factor-κB (NF-κB) signaling. 25, 35 The repression pathways mediated by LXRs have been elucidated in part from studies of macrophages lacking the nuclear receptor co-repressor (NCoR). 36 NCoR-deficient macrophages exhibit derepression of a subset of genes that are normally activated by AP1 and NF-κB in response to proinflammatory signals. Further investigation of these observations led to the finding that many TLR4 target genes are occupied under basal conditions by NCoR co-repressor complexes that function as transcriptional checkpoints and must be cleared as a prerequisite for lipopolysaccaride-dependent gene activation. 36 LXRs ligands were subsequently shown to inhibit TLR4-mediated activation of the gene encoding iNOS genes by preventing the turnover of NCoR, enabling NCoR complexes to maintain their repressive functions in the presence of an activating signal through TLR4. 25 These observations raise several questions. How is NCoR Macrophages, Oxysterols and Atherosclerosis cleared from TLR4-responsive genes inhibited by LXRs? Is there an analogous role for another corepressor, the silencing mediator of retinoic acid and thyroid hormone (SMRT) receptor? Are other repressor complexes involved in establishing basal transcriptional repression, and can all oxysterols inhibit TLR4-inducible genes through LXRs? Studies of the mechanisms of LXRs-dependent transcriptional repression have provided evidence for a model in which ligand binding to LXRs results in covalent attachment of small ubiquitin-related modifiers 2 and 3 (SUMO2 and SUMO3) to the ligand-binding domain of LXRs, using histone deacetylase 4 as the SUMO E3 ligase. 25 Following SUMOylation, LXRs targeted the NCoR complex where they prevent the recruitment of the ubiquitylation machinery necessary for NCoR clearance. As a result, the NCoR complex remains bound to the promoter region and continues to exert repressive activity even though proximal events in NF-κB activation have occurred. Recent studies have demonstrated that transrepression by LXRβ and the orphan receptor LRH-1 require SUMOylation to prevent NCoR turnover and suppress the acute phase response in the liver. 37 These studies further suggested that GPS2 is required for the docking of SUMOylated receptors to the NCoR complex.
The relative importance of NCoR and SMRT for LXRmediated transrepression in macrophages was recently established through studies in NCoR-and SMRT-deficient fetal liver macrophages. Deletion of NCoR resulted in almost complete loss of transrepression activity by LXRs in these cells. 38 Loss of SMRT expression also resulted in a loss of transrepression activity, affecting approximately 50% of the LXR-sensitive genes. Whereas a few LXR-sensitive genes were selectively dependent on SMRT, most of the SMRTdependent genes also required NCoR for transrepression. Thus, rather than being redundant, both corepressors were required for effective transrepression activity. Unexpectedly, this requirement reflected an interdependency of NCoR and SMRT for effective occupancy of target genes occupied by both corepressors: genetic deletion of NCoR resulted in loss of target gene occupancy by SMRT and vice versa. This interdependency provides a combinatorial basis for derepression in response to distinct signaling inputs. For example, IFNγ-signaling specifically targeting SMRT through the mitogenactivated protein kinase signaling pathway could result in derepression of SMRT-specific and NCoR -SMRT-responsive target genes, but not of genes selectively occupied by NCoR. 38 Intriguingly, the LXR-mediated transrepression pathway is itself subject to regulation. Whereas LXR ligands are potent inhibitors of TLR4-induced gene expression, they do not suppress TLR2-induced gene expression. 25 Investigation of the basis for this difference led to the unexpected observation that TLR2 and TLR4 induce NCoR clearance from target genes by different mechanisms. 39 TLR4-dependent NCoR clearance was found to require the p65 component of NF-κB, which acts as a messenger to deliver IKKε to NF-κB-binding sites in TLR4 target genes. Binding sites for NF-κB frequently occur in close proximity to AP1 motifs that are occupied by cJUN -NCoR corepressor complexes. This colocalization enables p65-associated IKKε to phosphorylate the N-terminus of cJUN, setting into motion recruitment of the ubiquitylation machinery and the 19S proteasome subunit. The mechanism by which cJUN phosphorylation initiates these events is not known, but requires the transducin β-like protein-1 (TBL1) and TBLR1 proteins, that are a component of corepressor complexes. This NCoR clearance pathway is sensitive to transrepression by LXR ligands. By contrast, NCoR clearance in response to ligation of TLR2 results from its ability to couple to phosphoinositide 3-kinase and rapidly mobilize intracellular calcium. This results in activation of Ca 2+ /calmodulin-dependent protein kinase II (Ca 2+ /CaMKII), which associates with the NCoR complex and phosphorylates the TBLR1 component. This directly activates the ability of TBLR1 to recruit the ubiquitylation machinery to the promoter and to initiate NCoR clearance, bypassing the requirement for phosphorylation of cJUN and enabling genes that do not contain juxtaposed AP1 and NF-κB sites to be derepressed. This pathway is not sensitive to transrepression by LXR ligands CaMKII is responsible for inactivating LXR-mediated transrepression in the context of TLR2 signaling, as treatment of macrophages with CaMKII inhibitors or knocking down the expression of CaMKIIγ restores the transrepression activities of LXR ligands. The mechanisms by which the catalytic activity of CaMKII inactivates the LXR-mediated transrepression pathway remain to be established.
Of note, some oxysterols cannot repress the inflammatory response. As mention before, in macrophages the activation of LXRs results in maintenance of cholesterol homeostasis through transcriptional activation, and suppression of the inflammatory response through transrepression. Interestingly, 22(R)-hydroxycholesterol, 24(S), 25-epoxycholetserol, and 24-hydroxycholesterol can both induce ABCA1 expression and repress iNOS activation through LXRs in macrophages, whereas 25-hydroxycholesterol and 27-hydroxycholesterol can activate ABCA1 but do not repress iNOS activation. 25 These findings suggest that the transactivation and transrepression activities of LXRs may be independently regulated according to the specific oxysterols that are produced under different conditions. Intriguingly, the oxysterols that induce transrepression are not found at any significant levels in cultured macrophages, whereas the oxysterols that are made at high levels by cultured macrophages do not induce transrepression. 40 It is possible that enzymes for producing oxysterols that activate this pathway are expressed in specific subsets of macrophages in vivo or are induced under inflammatory conditions. Moreover, this oxysterol-specificity suggests that it is possible to develop selective LXR modulators. Although synthetic LXR agonists exert anti-atherogenic effects, they also significantly raise circulating VLDL levels secondary to their effect on triglyceride biosynthesis in the liver. 41 Clinical application of LXR agonists for prevention of cardiovascular disease will require the development of selective LXR modulators that retain the ability to promote cholesterol efflux and inhibit inflammation, but do not raise circulating triglyceride levels. Therefore, understanding the mechanisms underlying oxysterol-specificity may help to develop such selective LXR modulators.
Besides SUMOylation-and NCoR/SMRT-dependent transrepression pathways, LXRs have also been shown to positively regulate the expression of anti-inflammatory molecules in macrophages, such as arginase II 42 and Mer receptor tyrosine kinase (Mertk). 43 Arginase II catalyzes the conversion of L-arginine to L-ornithine. Because both arginase II and iNOS utilize arginine as a common substrate, induction of arginase II expression has the potential to exert anti-inflammatory effects by the inhibition of NO production. In addition, the LXR pathway has recently been shown to be essential for efficient apoptotic cell clearance through positive induction of Mertk, 43 a member of the TAM family of receptor tyrosine kinases. In fact, LXR-deficient macrophages exhibit a selec-
2048
tive defect in phagocytosis of apoptotic cells and an aberrant proinflammatory response to them. 43 Therefore, LXRs activation contributes to immunomodulatory effects by both negative and positive regulation of inflammation-related genes. Interestingly, a recent study revealed that T-cell activation suppresses LXR target genes involved in cholesterol transport. 44 Ligand activation of LXR inhibits mitogen-driven T-cell expression through alteration of cholesterol content by ABCG1, whereas loss of LXR expression results in lymphoid hyperplasia and enhances antigen-driven responses. 44 These findings indicate that LXR is important for immune response in not only macrophages, but also T cells.
Oxysterol Regulation of the SREBP Pathway
Insulin-induced genes 1 and 2 (Insigs 1 and 2) are other well-known acceptors for oxysterols. 45 SREBPs, originally identified as basic helix -loop -helix (bHLH) leucine zipper transcription factors, are now established as global regulators of lipid synthesis. 46 SREBP1 is a potent activator of genes involved in the biosynthesis and esterification of fatty acid, whereas SREBP2 primarily activates genes involved in cholesterol metabolism, including the LDL receptor and HMGCoA reductase. SREBPs are synthesized and located on the endoplasmic reticulum (ER) membrane in their precursor form. To exert transcriptional activities, the active N-terminal region of the bHLH needs to undergo proteolytic cleavage for nuclear translocation. The SREBP cleavage-activating protein (SCAP) and Insigs function as cholesterol and oxysterol sensors, respectively. 45, 47 When the cellular cholesterol levels are depleted, SCAP binds to and escorts SREBP in COPII vesicles to the Golgi apparatus, where the site 1 and site 2 proteases cleave the SREBPs. 48, 49 Upon restoration of cellular cholesterol, Insig, another key regulator of ER membrane proteins, traps and retains the SREBP -SCAP complex at the ER to inhibit SREBP cleavage in the Golgi. Therefore, oxysterols can regulate cholesterol biosynthesis. Although little is known about the Insigs' function in macrophages, oxysterols, such as 22(R)-hydroxycholesterol and 24(S), 25-epoxycholesterol, can attenuate cholesterol biosynthesis, LDL receptor mRNA, and LDL receptor activity in macrophages. 23 Therefore, the SREBP/SCAP/Insigs pathway should play an important role in lipid metabolism regulation by oxysterols in macrophages. The ability of a subset of oxysterols to bind and regulate both Insigs and LXRs suggests that they play key roles as integrators of lipid metabolism (Figure 1) . With respect to cholesterol homeostasis, increased levels of these oxysterols would simultaneously suppress the SREBP2/SCAP/Insigs pathway to reduce de novo cholesterol biosynthesis and lipoprotein uptake, while activating the expression of LXR target genes that promote cholesterol efflux and degradation of LDL receptors. The effects of such oxysterols on fatty acid metabolism are more complex, because unlike the case of cholesterol homeostasis, where LXR and SREBP2 target genes are mutually exclusive, LXRs induce expression of SREBP1c, and LXRs and SREBP1 bind to and activate many of the same genes involved in de novo fatty acid biosynthesis. Because oxysterols also suppress processing of SREBP1, this scenario suggests that oxysterols both activate and repress fatty acid metabolism. Understanding how these opposing functions are regulated is an important area for future investigation.
Oxysterol-Binding Proteins
Besides the factors involved in transcriptional regulation of lipid metabolism-related genes, oxysterols are also recognized by cytosolic proteins, the OSBP and OSBP-related protein (ORP) family, and this recognition can affect lipid metabolism. In humans, there are at least 12 OSBP/ORP proteins, and they are characterized by a C-terminal oxysterols-binding domain and an N-terminal pleckstrin-homology domain that facilitates interaction with biological membrane, suggesting that the OSBP/ORP family influences cellular trafficking and modulates signal transduction (Figure 2A) . In fact, OSBP, ORP3, and ORP9 interact with vesicle-associated membrane protein-associated protein A and regulate export from the ER to the Golgi or plasma membrane. 50-52 ORP1L is located at the late endosome membrane and is a sterol-dependent regulator of late endosome positioning. 53,54 ORP2 localizes on cytoplasmic lipid droplets and the binding to oxysterols inhibits its lipid droplet association. 55 Although the mechanism still remains unclear, translocation of the OSBP/ORP family affects lipid metabolism, such as sphingomyelin, triglyceride, cholesterol, and cholesteryl esters. 50,54, 55 On the other hand, OSBP is a cholesterol-or 25-hydroxycholesterolregulated scaffolding protein for a member of the PTPPBS family of tyrosine phosphatases and the serine/threonine phosphatase PP2A, leading to control of the extracellular signal-regulated kinase signaling pathway. 56 Recent studies suggest that the OSBP/ORP family can also regulate cholesterol efflux. Knockdown of OSBP in J774 cells increases ABCA1 protein stability oxysterol-dependently. Interestingly, OSBP depletion does not affect ABCA1 mRNA and LXR activity. 57 Knockdown of ORP8 in THP-1 cells also increases ABCA1 mRNA and macrophage cholesterol efflux to ApoA-I and the suppressive effect involves an LXR response element in the ABCA1 promoter. 58 Transgenic overexpression of ORP1L in macrophages transplanted into the bone mar- Although the molecular mechanism of the regulation by the OSBP/ORP family remains unknown, positive and negative regulation of ABCA1 expression by oxysterols through LXRs and the OSBP/ORP family suggest that ABCA1 plays an important role in cholesterol homeostasis in macrophages and that these oxysterol receptors might be potential therapeutic targets for controlling cholesterol efflux from macrophages.
Oxysterols as Cytotoxic Factors
Many studies have detected oxysterols in human atherosclerotic plaque. 61-63 27-hydroxycholesterol is the major oxysterol in advanced atherosclerotic lesions and increases with the increasing severity of atherosclerosis. 64-67 After 27-hydroxycholesterol, 7-ketocholesterol is the most abundant oxysterol in advanced atherosclerotic lesions, followed by 7β-hydroxycholesterol and then 7α-hydroxycholesterol. Together these 4 oxysterols comprise 75-85% of the 9 oxysterols detected in plaques. 62, 63 The others are 5,6-epoxycholesterol, 25-hydroxycholesterol, and 24-hydroxycholesterol. Although there is no direct evidence in humans that oxysterols contribute to the development of atherosclerosis, these oxysterols are thought to play an active role in plaque development, because of their cytotoxicity. In fact, many studies have described the proapoptotic effect of oxysterols in various cells ( Figure 2B) . Apoptosis is the process of programmed cell death that is critical for normal embryonic development and for the maintenance of tissue homeostasis in the adult organism. It leads to characteristic cell changes and death. These changes include blebbing, cell shrinkage, nuclear fragmentation, and chromatin condensation. However, excessive apoptosis is thought to cause degenerative disease, such as atherosclerosis. In macrophages, 7-ketocholesterol, 68-70 7β-hydroxycholesterol, 70-72 5, 6-epoxycholesterol 71 and 25-hydroxycholesterol 72, 73 show activation of caspase-3, which is considered to be the most important effector caspase because it cleaves poly ADP-ribose polymerase that ultimately cause the morphological and biochemical changes seen in apoptotic cells. 74 The induction of apoptosis occurs mainly by 2 pathways: the cell death receptor pathway or the mitochondrial pathway. Oxysterols can induce apoptosis through both pathways. For example, the death receptor Fas is induced by 7β-hydroxycholesterol and the 7β-hydroxycholesterol-induced apoptosis is suppressed by co-treatment with the Fas/Fas ligand antagonist. 75 Bcl-2 family members are 1 of the main "apoptotic sensors" that act primarily on the mitochondria. 7β-hydroxycholesterol, 5,6-epoxycholesterol, and 25-hydroxycholesterol reduce the expression of antiapoptotic Bcl-2 protein in U937 or THP-1 cells, 72,75 whereas 7-ketohydroxycholesterol induces the expression of proapoptotic Bax protein in THP-1 cell. 68 Also, small interfering RNA knockdown of Bax in murine macrophage P388D1 cells resulted in a complete block of the induction of apoptosis by 25-hydroxycholesterol. 73 Although these findings clearly suggest that oxysterols affect the factors involved in the apoptosis signal and induce apoptosis, it raises the following question: What is the oxysterol acceptor for induction of apoptosis? Although some oxysterol acceptors have been reported, the molecular mechanisms remain unclear. In fact, the activation of LXRs prevents apoptosis in macrophages, induces anti-apopt-tic factors, such as AIM, and reduces proapoptotic factors, such as the Fas ligand. 76, 77 Further study is necessary to identify the critical oxysterol acceptors and details of the molecular mechanisms for apoptosis.
Conclusions
As we have discussed, oxysterols regulate 3 important aspects of macrophage biology: regulation of lipid transport and metabolism, inflammatory responses, and cytotoxicity. LXRs, Insigs, and OSBP/ORP family members have been identified as key acceptors for these functions of oxysterols. These acceptors provide entry points for further investigation of the molecular mechanisms by which oxysterols exert their effects. To date, most studies have focused on specific acceptors and downstream effects, even in the best-understood examples of the ability of LXRs and the SREBP/Insig pathways to coordinate cholesterol homeostasis. A major goal for the future will be to study how these pathways function in a coordinated manner in normal physiology and disease. In the case of atherosclerosis, it will be important to define the 
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relative roles of specific oxysterols in the regulation of lipid metabolism, inflammation and cell death. On the one hand, actions of a subset of oxysterols are likely to exert anti-atherosclerotic effects by enabling LXR to inhibit inflammatory responses and promoter cholesterol efflux. On the other hand, an overlapping but distinct set of oxysterols are likely to play an active role in development of vulnerable plaques, because of their cytotoxic effects. Sorting out the roles of specific oxysterols will be facilitated by the study of mouse models that lack the enzymes required for their production or lack the acceptor proteins that mediate their biological activities. In addition, synthetic molecules that act as specific antagonists or agonists of oxysterol acceptors will not only provide useful tools for evaluation of these pathways under normal and pathological conditions, but will provide direct information on the potential utility of targeting these pathways for therapeutic intervention.
